Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying American National Insurance Company (ANAT)

Page 1 of 2

Is American National Insurance Company (NASDAQ:ANAT) a buy?

At the moment, there are dozens of gauges shareholders can use to track the equity markets. A pair of the most underrated are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best money managers can outpace the S&P 500 by a very impressive amount (see just how much).

Just as crucial, bullish insider trading activity is another way to look at the stock market universe. There are a number of reasons for an upper level exec to drop shares of his or her company, but just one, very clear reason why they would buy. Many empirical studies have demonstrated the valuable potential of this method if you know where to look (learn more here).

What’s more, it’s important to discuss the recent info about American National Insurance Company (NASDAQ:ANAT).

American National Insurance Company (NASDAQ:ANAT)

How have hedgies been trading American National Insurance Company (NASDAQ:ANAT)?

At Q2’s end, a total of 9 of the hedge funds we track were bullish in this stock, a change of 13% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were increasing their holdings meaningfully.

According to our 13F database, Chuck Royce’s Royce & Associates had the most valuable position in American National Insurance Company (NASDAQ:ANAT), worth close to $14.4 million, comprising less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is Jim Simons of Renaissance Technologies, with a $1.6 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include D. E. Shaw’s D E Shaw, Ken Griffin’s Citadel Investment Group and Andy Redleaf’s Whitebox Advisors.

With a general bullishness amongst the titans, certain money managers have jumped into American National Insurance Company (NASDAQ:ANAT) headfirst. Royce & Associates, managed by Chuck Royce, established the most valuable position in American National Insurance Company (NASDAQ:ANAT). Royce & Associates had 14.4 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also initiated a $1.6 million position during the quarter. The other funds with new positions in the stock are D. E. Shaw’s D E Shaw, Ken Griffin’s Citadel Investment Group, and Andy Redleaf’s Whitebox Advisors.

How are insiders trading American National Insurance Company (NASDAQ:ANAT)?

Bullish insider trading is at its handiest when the company we’re looking at has experienced transactions within the past half-year. Over the latest 180-day time period, American National Insurance Company (NASDAQ:ANAT) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to American National Insurance Company (NASDAQ:ANAT). These stocks are Enstar Group Ltd. (NASDAQ:ESGR), Mercury General Corporation (NYSE:MCY), Corelogic Inc (NYSE:CLGX), The Hanover Insurance Group, Inc. (NYSE:THG), and Amtrust Financial Services, Inc. (NASDAQ:AFSI). This group of stocks are the members of the property & casualty insurance industry and their market caps are closest to ANAT’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!